Testosterone treatment for nerve protection and myelin repair in MS
Part of Brain & nervous system, Immune system & allergy clinical trials.
This Phase 2 study tests whether taking testosterone (for low testosterone levels) can help protect nerves and repair myelin in people with relapsing-remitting multiple sclerosis (MS). It may be most relevant if your MS is stable and you have low blood testosterone without current androgen treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a man aged 18 to 55
- You have relapsing-remitting MS that was officially diagnosed (not progressive MS)
- You are on an MS disease medicine (like natalizumab, fingolimod, ponesimod, ocrelizumab, or ofatumumab) for at least 1 year
- You have low testosterone on blood testing (total testosterone below 20 nmol/L)
- You have had no MS relapses in the past year and your MS has been stable recently
- You can get MRIs and have an EDSS disability score from 0 to 7
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether the drug ifenprodil can help repair the protective coating around nerves in people with relapsing-remitting MS. The goal is to see if it can improve vision-related nerve function, which may indicate overall nerve repair.
This Phase 2 study tests whether corticosteroid medicine can reduce inflammation at the edge of active multiple sclerosis (MS) plaques seen on MRI. It may help calm “hot” areas in the brain where MS activity is happening.
This trial tests a device that stimulates a nerve in the neck, which may help repair the protective coating around nerves in the brain and spinal cord. It is for people with relapsing-remitting MS who are stable on their current medication and have some vision problems due to MS.
This study looks at how aging affects the brain's ability to repair the protective coating around nerves (myelin) in people with MS. It tests methods to measure this repair process and may help find ways to slow down disability.
This trial tests a new treatment using a patient's own immune cells, modified with vitamin D3, to try to calm the immune system and slow the progression of multiple sclerosis (MS) without causing major side effects. It is for people with progressive MS who have not had recent relapses.
This study tests whether a medicine that targets a specific brain inflammation marker (TSPO) can help in people with certain types of multiple sclerosis. It focuses on safety and whether the target can be measured and influenced during treatment.
Hear when a new Multiple Sclerosis, Relapsing-Remitting trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.